189 related articles for article (PubMed ID: 35637633)
1. A novel DNA methylation-driver gene signature for long-term survival prediction of hepatitis-positive hepatocellular carcinoma patients.
Fu J; Qin W; Tong Q; Li Z; Shao Y; Liu Z; Liu C; Wang Z; Xu X
Cancer Med; 2022 Dec; 11(23):4721-4735. PubMed ID: 35637633
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
He D; Liao S; Cai L; Huang W; Xie X; You M
BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
[TBL] [Abstract][Full Text] [Related]
4. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
[TBL] [Abstract][Full Text] [Related]
5. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
6. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
Yu X; Yang R; He Z; Li K; Zeng P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
[TBL] [Abstract][Full Text] [Related]
11. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
12. A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma.
Wang Y; Ruan Z; Yu S; Tian T; Liang X; Jing L; Li W; Wang X; Xiang L; Claret FX; Nan K; Guo H
Aging (Albany NY); 2019 Jan; 11(1):160-173. PubMed ID: 30631005
[TBL] [Abstract][Full Text] [Related]
13. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
15. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
[TBL] [Abstract][Full Text] [Related]
16. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
19. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.
Ouyang G; Yi B; Pan G; Chen X
Cancer Cell Int; 2020; 20():207. PubMed ID: 32514252
[TBL] [Abstract][Full Text] [Related]
20. A prediction nomogram for hepatitis B virus-associated hepatocellular carcinoma.
Zhang Y; Wan G; Li H; Gao L; Liu N; Gao P; Liu Y; Gao X; Duan X
Scand J Gastroenterol; 2024; 59(1):70-77. PubMed ID: 37647217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
